BioTelemetry, Inc. (BEAT) Reaches $26.80 After 8.00% Up Move; Intercontinentalexchange Has 1.07 Sentiment

December 6, 2017 - By Winifred Garcia

The stock of BioTelemetry, Inc. (NASDAQ:BEAT) is a huge mover today! The stock increased 2.10% or $0.55 during the last trading session, reaching $26.8. About 625,336 shares traded or 0.90% up from the average. BioTelemetry, Inc. (NASDAQ:BEAT) has risen 87.79% since December 6, 2016 and is uptrending. It has outperformed by 71.09% the S&P500.The move comes after 7 months positive chart setup for the $868.54M company. It was reported on Dec, 6 by Barchart.com. We have $28.94 PT which if reached, will make NASDAQ:BEAT worth $69.48M more.

Intercontinental Exchange, Inc. operates regulated exchanges, clearing houses, and listings venues for financial and commodity markets in the United States, the United Kingdom, Continental Europe, Israel, Canada, and Singapore. The company has market cap of $41.41 billion. It operates in two divisions, Trading and Clearing, and Data and Listings. It has a 25.75 P/E ratio. The firm operates marketplaces for trading and clearing an array of derivatives and securities contracts across various asset classes, including energy and agricultural commodities, interest rates, equities, equity and credit derivatives, exchange traded funds, bonds, and currencies.

Cortland Associates Inc Mo holds 7.52% of its portfolio in Intercontinental Exchange, Inc. for 594,447 shares. Wall Street Access Asset Management Llc owns 50,631 shares or 6.44% of their US portfolio. Moreover, Eminence Capital Lp has 5.86% invested in the company for 5.22 million shares. The California-based Meritage Group Lp has invested 5.59% in the stock. Three Bays Capital Lp, a Massachusetts-based fund reported 1.06 million shares.

The stock decreased 0.24% or $0.17 during the last trading session, reaching $70.78. About 1.61M shares traded. Intercontinental Exchange, Inc. (ICE) has risen 13.80% since December 6, 2016 and is uptrending. It has underperformed by 2.90% the S&P500.

Analysts await Intercontinental Exchange, Inc. (NYSE:ICE) to report earnings on February, 6. They expect $0.73 EPS, up 2.82% or $0.02 from last year’s $0.71 per share. ICE’s profit will be $427.07 million for 24.24 P/E if the $0.73 EPS becomes a reality. After $0.72 actual EPS reported by Intercontinental Exchange, Inc. for the previous quarter, Wall Street now forecasts 1.39% EPS growth.

Analysts await BioTelemetry, Inc. (NASDAQ:BEAT) to report earnings on February, 28. They expect $0.18 EPS, 0.00% or $0.00 from last year’s $0.18 per share. BEAT’s profit will be $5.83 million for 37.22 P/E if the $0.18 EPS becomes a reality. After $0.16 actual EPS reported by BioTelemetry, Inc. for the previous quarter, Wall Street now forecasts 12.50% EPS growth.

BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The company has market cap of $868.54 million. The firm operates in three divisions: Healthcare, Research, and Technology. It has a 20.11 P/E ratio. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders.

Investors sentiment decreased to 1.3 in Q2 2017. Its down 0.12, from 1.42 in 2017Q1. It worsened, as 18 investors sold BioTelemetry, Inc. shares while 58 reduced holdings. 41 funds opened positions while 58 raised stakes. 23.79 million shares or 8.10% more from 22.01 million shares in 2017Q1 were reported. Capstone Asset Management invested in 0.02% or 18,550 shares. Louisiana State Employees Retirement owns 11,700 shares for 0.02% of their portfolio. Gsa Cap Partners Llp invested 0.07% of its portfolio in BioTelemetry, Inc. (NASDAQ:BEAT). Piedmont Advisors Limited Liability Corp holds 0% of its portfolio in BioTelemetry, Inc. (NASDAQ:BEAT) for 6,196 shares. Ahl Ptnrs Ltd Liability Partnership holds 0.01% or 10,492 shares in its portfolio. 11,239 are owned by Vident Invest Advisory Ltd Liability Corp. Mutual Of America Cap Ltd Com holds 0% or 2,100 shares. Scout Invs Inc holds 0.12% or 122,675 shares. 1832 Asset Management L P invested in 800 shares. 11,865 were reported by Curbstone Financial Mgmt Corp. Moreover, Great West Life Assurance Can has 0% invested in BioTelemetry, Inc. (NASDAQ:BEAT) for 40,699 shares. Arizona State Retirement holds 0.01% or 14,900 shares in its portfolio. Perkins Management Incorporated holds 0.56% or 15,000 shares in its portfolio. D E Shaw Inc invested 0.01% of its portfolio in BioTelemetry, Inc. (NASDAQ:BEAT). Oberweis Asset has 25,700 shares for 0.24% of their portfolio.

Among 6 analysts covering BioTelemetry (NASDAQ:BEAT), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioTelemetry has $41 highest and $20 lowest target. $38.60’s average target is 44.03% above currents $26.8 stock price. BioTelemetry had 9 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Buy” rating by Dougherty & Company given on Tuesday, April 11. The stock has “Buy” rating by Dougherty & Company on Friday, December 2. Dougherty & Company maintained it with “Buy” rating and $20 target in Tuesday, July 28 report. On Thursday, November 30 the stock rating was maintained by Raymond James with “Buy”. The firm has “Buy” rating given on Tuesday, September 13 by Sidoti.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com